WLWeiwei Lu

Weiwei Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Weiwei Lu has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Yu Tao

    The First Affiliated Hospital of Soochow University, School of Basic Medical Sciences, Suzhou Medical College of Soochow University Suzhou China

    3 shared publications
  • Yufang Sun

    The First Affiliated Hospital of Soochow University, School of Basic Medical Sciences, Suzhou Medical College of Soochow University Suzhou China

    3 shared publications
  • Chen Shi

    The First Affiliated Hospital of Soochow University, School of Basic Medical Sciences, Suzhou Medical College of Soochow University Suzhou China

    2 shared publications
  • Dongsheng Jiang

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    2 shared publications
  • Fuhai Ji

    Department of Anesthesiology The First Affiliated Hospital of Soochow University Suzhou China

    2 shared publications
  • Gang Chen

    Jiangsu Key Laboratory of Drug Discovery and Translational Research For Brain Diseases Centre For Ion Channelopathy Soochow University Suzhou People's Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Migraine: Epidemiology, Risk Factors, Pathophysiology, and Treatment

    by Weiwei Lu, Yuan Zhang, Chen Shi, Yu Tao, Shaoxin Li, Yufang Sun, Fuhai Ji, Dongsheng Jiang, Terrance P. Snutch, Jin Tao

    Migraine is a common, disabling brain disorder that affects about 1 billion people worldwide and disproportionately burdens women and working‐age adults. Once viewed mainly as a vascular headache, migraine is now understood as a heterogeneous neurobiological syndrome arising from interactions among genetic susceptibility, hormonal influences, environmental exposures, and cortical, brainstem, trigeminovascular, and neuroinflammatory networks. Although calcitonin gene‐related peptide (CGRP)‐pathway therapies, gepants, and neuromodulation have transformed care, major gaps remain in disease stratification, prevention of chronification and management of special populations. Here, we review recent evidence on global and regional epidemiology, sex‐specific and environmental risk factors, and the transition from episodic to chronic migraine. We then examine current mechanistic models, focusing on cortical spreading depolarization, trigeminovascular signaling, CGRP biology, neurogenic inflammation, glial activation, and brain network dysfunction. We also assess acute and preventive treatment strategies, including ditans, gepants, monoclonal antibodies, and onabotulinumtoxinA, and discuss persistent challenges in pediatric, geriatric, and pregnancy‐associated migraine care. By integrating population, mechanistic and therapeutic perspectives, this review reframes migraine as a stratified brain network disorder rather than a uniform vascular pain syndrome. This synthesis highlights priorities for biomarker development, precision medicine, and more equitable implementation of effective migraine care.


  • Open Access

    ZBTB18 Dysfunction Promotes Neuropathic Pain via CHD4‐based Epigenetic Disinhibition of CLIC1 Channels in Sensory Neurons

    by Shoupeng Wang, Zitong Huang, Yu Tao, Yunmei Zhang, Yufang Sun, Dongsheng Jiang, Weiwei Lu, Fuhai Ji, Gang Chen, Min Xu, et al.

    Nerve injury‐induced reprogramming of sensory neuron gene expression is a key driver of neuropathic pain. However, the transcriptional networks that orchestrate this maladaptive plasticity remain largely undefined. Here, we identify the transcriptional repressor ZBTB18 as a critical regulator of this pathogenic process. Peripheral nerve injury markedly downregulated the level of ZBTB18 in the injured trigeminal ganglion (TG) of rats. Restoring ZBTB18 expression reverses injury‐induced mechanical allodynia, while its knockdown in naive TG neurons is sufficient to recapitulate neuropathic pain symptoms. Mechanistically, ZBTB18 directly represses Clic1 transcription by engaging a specific silencer element within its promoter. This repression is achieved through the recruitment of the nucleosome remodeling and deacetylase (NuRD) complex, an interaction mediated by the ZBTB18 BTB domain and the chromodomain helicase DNA‐binding protein 4 (CHD4). Disruption of this recruitment abrogates histone H3K27ac deacetylation at the Clic1 promoter, enhancing RNA polymerase II occupancy and driving Clic1 expression. Consequently, nerve injury‐induced loss of ZBTB18 relieves this epigenetic brake, leading to CLIC1 upregulation, increased chloride channel activity, and hyperexcitability of TG neurons that underlies mechanical hypersensitivity. In summary, these findings reveal a novel ZBTB18/NuRD/CLIC1 epigenetic axis in neuropathic pain and highlight this transcriptional pathway as a potential target for therapeutic intervention.

  • Top Cited Papers
    Open Access

    Targeting glial-orchestrated neuroinflammation in migraine pathophysiology

    by Weiwei Lu, Yuan Zhang, Chen Shi, Yu Tao, Shaoxin Li, Yufang Sun, Fuhai Ji, Gang Chen, Terrance P. Snutch, Jin Tao

    Migraine is a chronic neurological disorder characterized by severe headache, nausea, and sensitivity to light and sound, affecting approximately 1 billion


  • New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases

    by Pengchen Gu, Yuxin Wu, Weiwei Lu

    Cardiovascular diseases (CVDs) are the leading cause of death and disability worldwide. It is essential to develop novel interventions to prevent/delay CVDs by targeting their fundamental cellular and molecular processes. Melatonin is a small indole molecule acting both as a hormone of the pineal gland and as a local regulator molecule in various tissues. It has multiple features that may contribute to its cardiovascular protection. Moreover, melatonin enters all cells and subcellular compartments and crosses morphophysiological barriers. Additionally, this indoleamine also serves as a safe exogenous therapeutic agent. Increasing evidence has demonstrated the beneficial effects of melatonin in preventing and improving cardiovascular risk factors. Exogenous administration of melatonin, as a result of its antioxidant and anti-inflammatory properties, has been reported to decrease blood pressure, protect against atherosclerosis, attenuate molecular and cellular damage resulting from cardiac ischemia/reperfusion, and improve the prognosis of myocardial infarction and heart failure. This review aims to summarize the beneficial effects of melatonin against these conditions, the possible protective mechanisms of melatonin, and its potential clinical applicability in CVDs.


  • Open Access

    Endogenous Vasoactive Peptides and Vascular Aging‐Related Diseases

    by Yao Chen, Yongfen Qi, Weiwei Lu

    Vascular aging is a specific type of organic aging that plays a central role in the morbidity and mortality of cardiovascular and cerebrovascular diseases among the elderly. It is essential to develop novel interventions to prevent/delay age‐related vascular pathologies by targeting fundamental cellular and molecular aging processes. Endogenous vasoactive peptides are compounds formed by a group of amino acids connected by peptide chains that exert regulatory roles in intercellular interactions involved in a variety of biological and pathological processes. Emerging evidence suggests that a variety of vasoactive peptides play important roles in the occurrence and development of vascular aging and related diseases such as atherosclerosis, hypertension, vascular calcification, abdominal aortic aneurysms, and stroke. This review will summarize the cumulative roles and mechanisms of several important endogenous vasoactive peptides in vascular aging and vascular aging‐related diseases. In addition, we also aim to explore the promising diagnostic function as biomarkers and the potential therapeutic application of endogenous vasoactive peptides in vascular aging‐related diseases.


  • Open Access

    Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice

    by Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou

    Cardiac inflammation and fibrosis contribute significantly to hypertension-related adverse cardiac remodeling. IκB kinase β (IKK-β), a central coordinator of inflammation through activation of NF-κB, has been demonstrated as a key molecular link between inflammation and cardiovascular disease. However, the cell-specific contribution of IKK-β signaling toward adverse cardiac remodeling remains elusive. Cardiac fibroblasts are one of the most populous nonmyocyte cell types in the heart that play a key role in mediating cardiac fibrosis and remodeling. To investigate the function of fibroblast IKK-β, we generated inducible fibroblast-specific IKK-β–deficient mice. Here, we report an important role of IKK-β in the regulation of fibroblast functions and cardiac remodeling. Fibroblast-specific IKK-β–deficient male mice were protected from angiotensin II–induced cardiac hypertrophy, fibrosis, and macrophage infiltration. Ablation of fibroblast IKK-β inhibited angiotensin II–stimulated fibroblast proinflammatory and profibrogenic responses, leading to ameliorated cardiac remodeling and improved cardiac function in IKK-β–deficient mice. Findings from this study establish fibroblast IKK-β as a key factor regulating cardiac fibrosis and function in hypertension-related cardiac remodeling.


  • Open Access

    Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages

    by Jin-Ling Ren, Yao Chen, Lin-Shuang Zhang, Ya-Rong Zhang, Shi-Meng Liu, Yan-Rong Yu, Mo-Zhi Jia, Chao-Shu Tang, Yong-Fen Qi, Wei-Wei Lu

    Atherosclerotic plaque vulnerability and rupture increase the risk of acute coronary syndromes. Advanced lesion macrophage apoptosis plays important role in the rupture of atherosclerotic plaque, and endoplasmic reticulum stress (ERS) has been proved to be a key mechanism of macrophage apoptosis. Intermedin (IMD) is a regulator of ERS. Here, we investigated whether IMD enhances atherosclerotic plaque stability by inhibiting ERS-CHOP-mediated apoptosis and subsequent inflammasome in macrophages. We studied the effects of IMD on features of plaque vulnerability in hyperlipemia apolipoprotein E-deficient (ApoE−/−) mice. Six-week IMD1-53infusion significantly reduced atherosclerotic lesion size. Of note, IMD1-53lowered lesion macrophage content and necrotic core size and increased fibrous cap thickness and vascular smooth muscle cells (VSMCs) content thus reducing overall plaque vulnerability. Immunohistochemical analysis indicated that IMD1-53administration prevented ERS activation in aortic lesions of ApoE−/−mice, which was further confirmed in oxidized low-density lipoproteins (ox-LDL) induced macrophages. Similar to IMD, taurine (Tau), a non-selective ERS inhibitor significantly reduced atherosclerotic lesion size and plaque vulnerability. Moreover, C/EBP-homologous protein (CHOP), a pro-apoptosis transcription factor involved in ERS, was significantly increased in advanced lesion macrophages, and deficiency of CHOP stabilized atherosclerotic plaques in AopE−/−mice. IMD1-53decreased CHOP level and apoptosis in vivo and in macrophages treated with ox-LDL. In addition, IMD1-53infusion ameliorated NLRP3 inflammasome and subsequent proinflammatory cytokines in vivo and in vitro. IMD may attenuate the progression of atherosclerotic lesions and plaque vulnerability by inhibiting ERS-CHOP-mediated macrophage apoptosis, and subsequent NLRP3 triggered inflammation. The inhibitory effect of IMD on ERS-induced macrophages apoptosis was probably mediated by blocking CHOP activation.


  • Ghrelin inhibited pressure overload–induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway

    by Weiwei Lu, Huaiqiu Cai, Yao Chen, Xiang Liao, Linshuang Zhang, Tongtong Ma, Hong Sun, Yongfen Qi